Teladoc Stock Analysis
TDOC Stock | USD 14.33 0.82 6.07% |
Teladoc is overvalued with Real Value of 12.06 and Target Price of 10.95. The main objective of Teladoc stock analysis is to determine its intrinsic value, which is an estimate of what Teladoc is worth, separate from its market price. There are two main types of Teladoc's stock analysis: fundamental analysis and technical analysis.
The Teladoc stock is traded in the USA on New York Stock Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Teladoc's ongoing operational relationships across important fundamental and technical indicators.
Teladoc |
Teladoc Stock Analysis Notes
About 77.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.64. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Teladoc recorded a loss per share of 5.78. The entity had not issued any dividends in recent years. Teladoc Health, Inc. provides virtual healthcare services in the United States and internationally. The company was incorporated in 2002 and is headquartered in Purchase, New York. Teladoc Health operates under Health Information Services classification in the United States and is traded on New York Stock Exchange. It employs 4335 people. To find out more about Teladoc contact CPA III at 203 635 2002 or learn more at https://www.teladochealth.com.Teladoc Quarterly Total Revenue |
|
Teladoc Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Teladoc's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Teladoc or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Teladoc appears to be risky and price may revert if volatility continues | |
The company reported the previous year's revenue of 2.6 B. Net Loss for the year was (220.37 M) with profit before overhead, payroll, taxes, and interest of 1.83 B. | |
Teladoc has a frail financial position based on the latest SEC disclosures | |
Over 77.0% of the company shares are owned by institutional investors | |
Latest headline from finance.yahoo.com: Teladoc Health, Inc. Among the Health Information Services Stocks Outpacing the Market in 2025 |
Teladoc Upcoming and Recent Events
Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Teladoc previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
28th of February 2024 Upcoming Quarterly Report | View | |
24th of April 2024 Next Financial Report | View | |
31st of December 2023 Next Fiscal Quarter End | View | |
28th of February 2024 Next Fiscal Year End | View | |
30th of September 2023 Last Quarter Report | View | |
31st of December 2022 Last Financial Announcement | View |
Teladoc Largest EPS Surprises
Earnings surprises can significantly impact Teladoc's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
---|---|---|---|---|---|---|---|
2024-02-20 | 2023-12-31 | -0.21 | -0.17 | 0.04 | 19 | ||
2020-04-29 | 2020-03-31 | -0.36 | -0.4 | -0.04 | 11 | ||
2017-05-08 | 2017-03-31 | -0.34 | -0.3 | 0.04 | 11 |
Teladoc Environmental, Social, and Governance (ESG) Scores
Teladoc's ESG score is a quantitative measure that evaluates Teladoc's performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of Teladoc's operations that may have significant financial implications and affect Teladoc's stock price as well as guide investors towards more socially responsible investments.
Teladoc Thematic Classifications
In addition to having Teladoc stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
![]() | Corona OpportunityCoronavirus related entities to consider during and after the outbreak |
Teladoc Stock Institutional Investors
Shares | Voloridge Investment Management, Llc | 2024-09-30 | 2.4 M | Morgan Stanley - Brokerage Accounts | 2024-09-30 | 2.4 M | Jpmorgan Chase & Co | 2024-09-30 | 2.3 M | Pale Fire Capital Se | 2024-09-30 | 2 M | Barclays Plc | 2024-09-30 | 2 M | Connor Clark & Lunn Inv Mgmt Ltd | 2024-09-30 | 1.7 M | Ameriprise Financial Inc | 2024-09-30 | 1.5 M | Northern Trust Corp | 2024-09-30 | 1.5 M | Invenomic Capital Management, Lp | 2024-09-30 | 1.5 M | Blackrock Inc | 2024-09-30 | 18.2 M | Vanguard Group Inc | 2024-09-30 | 17.4 M |
Teladoc Market Capitalization
The company currently falls under 'Mid-Cap' category with a current market capitalization of 2.47 B.Teladoc Profitablity
The company has Profit Margin (PM) of (0.38) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.06) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.06.Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (0.15) | (0.16) | |
Return On Capital Employed | (0.06) | (0.05) | |
Return On Assets | (0.06) | (0.06) | |
Return On Equity | (0.09) | (0.11) |
Management Efficiency
Teladoc has return on total asset (ROA) of (0.0313) % which means that it has lost $0.0313 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.5165) %, meaning that it created substantial loss on money invested by shareholders. Teladoc's management efficiency ratios could be used to measure how well Teladoc manages its routine affairs as well as how well it operates its assets and liabilities. As of February 16, 2025, Return On Tangible Assets is expected to decline to -0.16. The current year's Return On Capital Employed is expected to grow to -0.05. At present, Teladoc's Non Currrent Assets Other are projected to increase significantly based on the last few years of reporting. The current year's Other Assets is expected to grow to about 58.6 M, whereas Total Assets are forecasted to decline to about 4.9 B.Last Reported | Projected for Next Year | ||
Book Value Per Share | 12.91 | 12.26 | |
Tangible Book Value Per Share | (3.01) | (2.86) | |
Enterprise Value Over EBITDA | 23.16 | 24.32 | |
Price Book Value Ratio | 1.73 | 1.64 | |
Enterprise Value Multiple | 23.16 | 24.32 | |
Price Fair Value | 1.73 | 1.64 | |
Enterprise Value | 3.6 B | 5.9 B |
The management team at Teladoc has a track record of steering the company towards sustained growth. Evaluating their strategies helps in understanding the stock's long-term potential.
Technical Drivers
As of the 16th of February 2025, Teladoc has the Semi Deviation of 2.9, risk adjusted performance of 0.1303, and Coefficient Of Variation of 581.2. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Teladoc, as well as the relationship between them.Teladoc Price Movement Analysis
The output start index for this execution was nineteen with a total number of output elements of fourty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Teladoc middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Teladoc. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Teladoc Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Teladoc insiders, such as employees or executives, is commonly permitted as long as it does not rely on Teladoc's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Teladoc insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Teladoc Outstanding Bonds
Teladoc issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Teladoc uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Teladoc bonds can be classified according to their maturity, which is the date when Teladoc has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
MPLX LP 4125 Corp BondUS55336VAK61 | View | |
MPLX LP 4875 Corp BondUS55336VAJ98 | View | |
MPLX LP 52 Corp BondUS55336VAL45 | View | |
Valero Energy Partners Corp BondUS91914JAA07 | View |
Teladoc Predictive Daily Indicators
Teladoc intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Teladoc stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Teladoc Corporate Filings
14th of February 2025 Other Reports | ViewVerify | |
10th of January 2025 Other Reports | ViewVerify | |
F4 | 23rd of December 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
F4 | 3rd of December 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
13A | 12th of November 2024 An amended filing to the original Schedule 13G | ViewVerify |
10Q | 31st of October 2024 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
8K | 30th of October 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
13A | 23rd of October 2024 An amended filing to the original Schedule 13G | ViewVerify |
Teladoc Forecast Models
Teladoc's time-series forecasting models are one of many Teladoc's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Teladoc's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Teladoc Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Teladoc prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Teladoc shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Teladoc. By using and applying Teladoc Stock analysis, traders can create a robust methodology for identifying Teladoc entry and exit points for their positions.
Last Reported | Projected for Next Year | ||
Pretax Profit Margin | (0.10) | (0.10) | |
Operating Profit Margin | (0.09) | (0.08) | |
Net Loss | (0.10) | (0.10) | |
Gross Profit Margin | 0.81 | 0.78 |
Current Teladoc Analysis - Recommendations
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Teladoc analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Teladoc analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target Price | Advice | # of Analysts | |
10.95 | Buy | 25 | Odds |
Most Teladoc analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Teladoc stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Teladoc, talking to its executives and customers, or listening to Teladoc conference calls.
Teladoc Stock Analysis Indicators
Teladoc stock analysis indicators help investors evaluate how Teladoc stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Teladoc shares will generate the highest return on investment. By understating and applying Teladoc stock analysis, traders can identify Teladoc position entry and exit signals to maximize returns.
Begin Period Cash Flow | 918.2 M | |
Long Term Debt | 1.5 B | |
Common Stock Shares Outstanding | 164.6 M | |
Total Stockholder Equity | 2.3 B | |
Tax Provision | 760 K | |
Property Plant And Equipment Net | 72.1 M | |
Cash And Short Term Investments | 1.1 B | |
Cash | 1.1 B | |
Accounts Payable | 43.6 M | |
Net Debt | 468.6 M | |
50 Day M A | 10.415 | |
Total Current Liabilities | 420.6 M | |
Other Operating Expenses | 2.9 B | |
Non Current Assets Total | 2.9 B | |
Forward Price Earnings | 357.1429 | |
Non Currrent Assets Other | 80.3 M | |
Stock Based Compensation | 201.6 M |
Complementary Tools for Teladoc Stock analysis
When running Teladoc's price analysis, check to measure Teladoc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Teladoc is operating at the current time. Most of Teladoc's value examination focuses on studying past and present price action to predict the probability of Teladoc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Teladoc's price. Additionally, you may evaluate how the addition of Teladoc to your portfolios can decrease your overall portfolio volatility.
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |